The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data.
The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an ...
This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we have proven—and continue to prove—how unlocking the power ...
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map ...
US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the ...
The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network Concentric is building a global pathogen monitoring network—a ...
A technician works among a fleet of desktop genomic sequencing machines at the Cancer Genomics Research Laboratory, part of the National Cancer Institute. (Photo by Daniel Sone/National Cancer ...
Illumina is struggling to get customers to buy its newest products. Wall Street's estimates don't seem to account for that challenge. It may also have to divest its cancer testing company soon. The ...